Analysis of the safety and feasibility of sleeve resection under UniVATS after neoadjuvant chemotherapy combined with immunotherapy for locally advanced central-type non-small cell lung cancer
Sleeve resection after neoadjuvant chemotherapy combined with immunotherapy for locally advanced central-type NSCLC under single-port thoracoscopy is safe and feasible and provides short-term postoperative benefits for patients.
Authors
- Yuxuan Zhou (ORCID: https://orcid.org/0000-0002-0432-1720)
- Guidong Shi (ORCID: https://orcid.org/0000-0002-1238-6575)
- Yue Li (ORCID: https://orcid.org/0009-0009-4953-4939)
- Liwen Zhang (ORCID: https://orcid.org/0000-0001-9816-1344)
- Chengcheng Zhang (ORCID: https://orcid.org/0000-0002-0550-107X)
- Hao Yang (ORCID: https://orcid.org/0000-0001-9358-9173)
- Bo Yang (ORCID: https://orcid.org/0000-0002-2270-8101)
- Maoyong Fu
- Yue Zhang (ORCID: https://orcid.org/0000-0002-7786-0231)
Institutions
- Affiliated Hospital of North Sichuan Medical College (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1186/s12957-024-03462-x
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00